Back to Results

Neuberger Berman High Yield Strategies (NHS)

Neuberger Berman High Yield Strategies (NYSE: NHS) is a closed-end fixed income fund listed on the New York Stock Exchange. Managed by Neuberger Berman Investment Advisers LLC and launched by Neuberger Berman LLC, the fund seeks exposure to global fixed income markets, with a focus on high yield debt securities across a range of industries. The portfolio scope described in the source includes sectors such as auto parts and equipment, airlines, automotive, electronics, health services, packaging, telecom services, gaming, and gas distribution. Formerly known as Neuberger High Yield Strategies Fund, the fund was formed on July 28, 2003 and is domiciled in the United States.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-NHS
—
—
—
—
—
—
Fair
July 15, 2026
July 31, 2026
1.086
17.8%
—
—
—
—
191.8 M
—
—
—
—
160.3%
—
Valuation • Fair Value

Neuberger Berman High Yield Strategies (NYSE-NHS) Fair Value by Valuation Model

Compare the primary fair value estimate for Neuberger Berman High Yield Strategies (NYSE-NHS) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

Not available

Data is currently unavailable.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

NM

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Neuberger Berman High Yield Strategies (NYSE-NHS) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Neuberger Berman High Yield Strategies (NYSE-NHS)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

23.614 M

Current operating scale indicator.

Revenue Forecast

Not available

Data is currently unavailable.

EBITDA

0 K

Current operating profitability reference.

EBITDA Forecast

Not available

Data is currently unavailable.

How to read profitability and growth

This section helps investors review Neuberger Berman High Yield Strategies (NYSE-NHS) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Neuberger Berman High Yield Strategies (NYSE-NHS)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

Not available

Data is currently unavailable.

Beneish M-Score

Not available

Data is currently unavailable.

Altman Z-Score

Not available

Data is currently unavailable.

FCF / Net Income

Not available

Data is currently unavailable.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Neuberger Berman High Yield Strategies (NYSE-NHS). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Neuberger Berman High Yield Strategies (NYSE-NHS)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

Not available

Days to Earnings

Not available

Dividend Payment Date

July 31, 2026

Ex-Dividend Date

July 15, 2026

Dividend Yield

17.8%

Income yield reference.

Upcoming Dividend

1.086

Upcoming distribution amount.

Payment Type

Cash

Distribution type as reported in the data.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

160.3%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Neuberger Berman High Yield Strategies (NYSE-NHS), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Neuberger Berman High Yield Strategies (NYSE-NHS) Stock Forecast & Technical Outlook

Review Neuberger Berman High Yield Strategies (NYSE-NHS) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Neuberger Berman High Yield Strategies (NYSE-NHS) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Neuberger Berman High Yield Strategies (NYSE-NHS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Neuberger Berman High Yield Strategies (NYSE-NHS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Neuberger Berman High Yield Strategies (NYSE-NHS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Neuberger Berman High Yield Strategies (NYSE-NHS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Neuberger Berman High Yield Strategies (NYSE-NHS)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Neuberger Berman High Yield Strategies (NYSE-NHS) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ • Fast Investor Answers

Neuberger Berman High Yield Strategies (NYSE-NHS) Stock FAQ

Quick answers about Neuberger Berman High Yield Strategies (NYSE-NHS) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
Not available
Data is currently unavailable
Valuation Rating
Not available
Classification is not available
Analyst Target
Not available
Data is currently unavailable
Financial Health
Fair
Current financial-health read

A fair value estimate for Neuberger Berman High Yield Strategies (NYSE-NHS) is not currently available in the latest data file.

A clear undervalued or overvalued classification is not currently available in the latest data file.

An analyst price target for Neuberger Berman High Yield Strategies (NYSE-NHS) is not currently available in the latest data file.

The current financial health read for Neuberger Berman High Yield Strategies (NYSE-NHS) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Based on the current data, dividend yield is 17.8%, upcoming dividend amount is 1.086, ex-dividend date is July 15, 2026, payment date is July 31, 2026.

The current market capitalization listed for Neuberger Berman High Yield Strategies is 191.8 M.

The ticker symbol for Neuberger Berman High Yield Strategies is NYSE-NHS, and the stock is listed on NYSE.

Neuberger Berman High Yield Strategies (NYSE-NHS) is listed on NYSE.

Similar Capital Markets Stocks on NYSE View more

Morgan Stanley (MS) Morgan Stanley (MS)
Morgan Stanley Pa ADR (MS_PA) Morgan Stanley Pa ADR (MS_PA)
Morgan Stanley Pe ADR (MS_PE) Morgan Stanley Pe ADR (MS_PE)
Morgan Stanley Pf ADR (MS_PF) Morgan Stanley Pf ADR (MS_PF)
Morgan Stanley Pi ADR (MS_PI) Morgan Stanley Pi ADR (MS_PI)
Morgan Stanley Pref K (MS_PK) Morgan Stanley Pref K (MS_PK)
Goldman Sachs Group Inc (GS) Goldman Sachs Group Inc (GS)
Goldman Sachs Group Inc Pa ADR (GS_PA) Goldman Sachs Group Inc Pa ADR (GS_PA)
Goldman Sachs Group Inc Pc ADR (GS_PC) Goldman Sachs Group Inc Pc ADR (GS_PC)
Goldman Sachs Group Inc Pd ADR (GS_PD) Goldman Sachs Group Inc Pd ADR (GS_PD)
Charles Schwab Corp (SCHW) Charles Schwab Corp (SCHW)
BlackRock Inc (BLK) BlackRock Inc (BLK)
UBS Group AG (UBS) UBS Group AG (UBS)
Blackstone Inc (BX) Blackstone Inc (BX)
S&P Global Inc (SPGI) S&P Global Inc (SPGI)
Bank of New York Mellon Corp (BNY) Bank of New York Mellon Corp (BNY)
Brookfield Corp (BN) Brookfield Corp (BN)
Moodys Corporation (MCO) Moodys Corporation (MCO)
KKR & Co Inc Preferred (KKR_pd) KKR & Co Inc Preferred (KKR_pd)
KKR & Co LP (KKR) KKR & Co LP (KKR)
Intercontinental Exchange Inc (ICE) Intercontinental Exchange Inc (ICE)
Brookfield Asset Management Inc (BAM) Brookfield Asset Management Inc (BAM)
Deutsche Bank AG (DB) Deutsche Bank AG (DB)
State Street Corp (STT) State Street Corp (STT)